Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cochlear Hearing Loss

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Cochlear Hearing Loss in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Prell, CG1
Yagi, M1
Kawamoto, K1
Beyer, LA1
Atkin, G1
Raphael, Y1
Dolan, DF1
Bledsoe, SC1
Moody, DB1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Cochlear Hearing Loss

ArticleYear
Chronic excitotoxicity in the guinea pig cochlea induces temporary functional deficits without disrupting otoacoustic emissions.
    The Journal of the Acoustical Society of America, 2004, Volume: 116, Issue:2

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Audiometry, Evoked Response; Audi

2004